The main aims of the CSPRG are to reduce the incidence of colorectal cancer (CRC) in the general population and in high-risk groups, and to detect the disease at an early, curable stage. We are one of the only groups in the country conducting large population-based studies and trials to test hypotheses in this research area and provide evidence to facilitate change in clinical practice. We provide high quality evidence to inform policy and influence national and international guidelines relating to CRC screening, surveillance, and diagnosis/referral pathways.
Over the next five-year funding period, we have four key areas of focus:
1. CRC screening
2. Surveillance of high-risk groups
3. Proximal colon cancer prevention and early detection
4. Improving diagnosis in symptomatic patients.